StockWatch
·

Galaxy Surfactants Ltd Q2 FY27 Results

GALAXYSURFQ2 FY27 Results
Filing
Result:Very Good· Market: Down#Broad based#Margin expansion
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue1.8K1.6%36.5%
Total Income1.8K1.8%36.4%
Expenditure1.7K5.5%33.0%
PBT151.2127.0%90.9%
Net Profit119.7527.8%80.1%
OPM10.47%3.52pp2.14pp
NPM6.59%2.70pp1.60pp
EPS33.7827.8%80.2%
View full financials

Revenue grew 36.5% YoY with EBITDA/NPM margins expanding sharply (OPM 8.3%→10.5%, NPM 5.0%→6.6%), driving 80% adjusted PAT growth — a core-business-led standout continuing the strong momentum seen in Q1 FY27, not a one-off or base-effect beat.

Galaxy Surfactants Q2 FY27 Revenue Up 36.4% YoY to ₹1,816.8 Cr

04 Nov 2026 · 4 Nov, 11:11 pm

Summary

Galaxy Surfactants Limited reported strong financial results for Q2 FY27, with total revenue growing 36.4% year-on-year to ₹1,816.8 crore. The company's EBITDA saw a substantial increase of 68.4% to ₹195.9 crore, and Profit After Tax (PAT) grew by 80.1% to ₹119.8 crore. This performance was driven by high-single-digit volume growth, particularly in India and AMET regions, and a richer Specialty Care portfolio mix. Management expressed confidence in delivering sustainable and profitable growth, noting that H1 FY27 PAT already exceeded the full FY26 PAT.

Key Highlights

  1. 1

    Galaxy Surfactants Limited announced its Q2 FY27 consolidated performance, showcasing robust earnings momentum driven by volume growth and a richer Specialty Care portfolio mix.

  2. 2

    Total Revenue for Q2 FY27 reached ₹1,816.8 crore, marking a significant 36.4% year-on-year increase.

  3. 3

    EBITDA for the quarter surged by 68.4% year-on-year to ₹195.9 crore, driven by volume-led growth and an improved Specialty Care mix.

  4. 4

    Profit After Tax (PAT) for Q2 FY27 grew by an impressive 80.1% year-on-year to ₹119.8 crore.

  5. 5

    Consolidated volumes registered high-single-digit growth on a YoY basis, with strong mid-teens growth observed in the India and AMET regions.

  6. 6

    EBITDA per metric tonne (MT) increased by 56% to ₹26,920/MT, reflecting operational efficiencies and favourable product mix.

  7. 7

    PAT for the first six months of FY27 has already surpassed the PAT delivered for the entire previous financial year, representing a significant milestone.

Management Comments

K

K. Natarajan

We are pleased with the strong performance delivered in Q2 FY27. The broad-based growth in India, continued recovery in AMET and sustained momentum in Specialty Care demonstrate the strength and resilience of our business. Our ability to make disciplined commercial decisions and leverage our diversified portfolio has enabled us to deliver a robust performance despite a challenging external environment. The performance over the last two quarters also reflects the exceptional efforts and collaboration of our teams across business development, commercial excellence, procurement, global logistics, manufacturing and operations. Their agility, commitment and focused execution have ensured business continuity amid significant external disruptions. With an improving business mix and continued momentum in Specialty Care, we remain confident in delivering sustainable and profitable growth. Importantly, PAT for the first six months of FY27 has already surpassed the PAT delivered for the entire previous financial year, making a significant milestone for the company. Demand indicators remain encouraging across key markets, with healthy consumption trends in India, improving conditions in AMET and positive Specialty Care demand across geographies. The Company remains vigilant regarding developments in West Asia and their potential implications for global logistics, freight rates and feedstock availability.

Informational and educational content only. Not investment advice.